title: Erythropoietin induced tumour mass reduction in murine lymphoproliferative models.
authors.affiliation: Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
authors.forename: Odelia
authors.initials: O
authors.lastname: Katz
authors.forename: Eran
authors.initials: E
authors.lastname: Barzilay
authors.forename: Alon
authors.initials: A
authors.lastname: Skaat
authors.forename: Amir
authors.initials: A
authors.lastname: Herman
authors.forename: Moshe
authors.initials: M
authors.lastname: Mittelman
authors.forename: Drorit
authors.initials: D
authors.lastname: Neumann
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D004195:Disease Models, Animal; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D015448:Leukemia, B-Cell / Q000188:drug therapy / Q000473:pathology; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D010954:Plasmacytoma / Q000188:drug therapy / Q000473:pathology; D011994:Recombinant Proteins
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa